Business Signals Copy RSS link Link copied to clipboard!
Northern Electric suspends preference share trading due to audit delay
Northern Electric PLC has temporarily suspended trading of its preference shares on the London Stock Exchange following a delay in publishing its statutory annual report. The delay was caused by a technical issue encountered during the audit process. Regulatory mechanisms have intervened to pause trading activity until the required financial disclosures are completed and released. The company states the suspension is temporary and will remain in place only until the accounts are finalised. Once released, the company intends to request the lifting of the suspension to restore normal market conditions.
Western Digital and SanDisk shares fall over 7% and 6% respectively in pre-market trading despite strong earnings
Western Digital and SanDisk shares dropped more than 7% and 6% respectively in pre-market trading on Friday, despite reporting earnings that exceeded market expectations. Analysts noted that the companies' guidance lacked sufficient surprises. This occurred alongside broader market activity where major U.S. stock index futures rose, driven by geopolitical developments involving Iran and the United States, and positive earnings reports from Apple, Reddit, Atlassian, Twilio, Roku, Estee Lauder, and Moderna.
Investors trade stakes worth up to Rs 29.8 crore in three stocks
Bulk deal activity recorded in Rossari Biotech, AAA Technologies, and Sun Pharma Advanced Research Company Ltd. Bupesh Kumar bought 2.98 lakh shares in Rossari Biotech worth Rs 14.64 crore. North Star bought 1.01 lakh shares in AAA Technologies worth Rs 1.01 crore while Golden Bio Energy sold 84,370 shares worth Rs 1.83 crore. PSL Limited sold 2 million shares in Sun Pharma Advanced Research Company worth Rs 29.8 crore. Transactions reflect mixed investor positioning across the companies.
Monolithic Power Systems raises guidance after Q1 earnings beat
Monolithic Power Systems reported Q1 2026 sales of US$804.19 million and net income of US$193.23 million, exceeding analyst expectations. The company raised its forward guidance and outlined higher manufacturing capacity targets. Supported by demand in communications and enterprise data markets, the results coincided with a 47.66% share price return over 30 days. The company also resolved a patent dispute. Analysts note the stock trades above the average price target, with some viewing it as overvalued relative to fair value models.
East Star Resources Plc faces temporary suspension amid FTSE reporting timeline
East Star Resources Plc announced a delay in releasing its annual financial report due to a tax review involving its Kazakhstan-based subsidiary. Consequently, trading in the company's shares has been temporarily suspended until the audited accounts are published. The company stated the delay is procedural and relates to compliance requirements, with no impact on operational continuity. Trading is expected to resume once the financial statements are formally released.
Gates Industrial Corporation misses Q1 CY2026 revenue estimates
Gates Industrial Corporation reported Q1 CY2026 revenue of $851.1 million, missing analyst estimates of $862.7 million and remaining flat year on year. While non-GAAP profit of $0.35 per share beat expectations by 6.5%, organic revenue fell 2.9% and operating margin declined to 12.9% from 14.7%. CEO Ivo Jurek noted successful ERP implementation in Europe and solid order rates. The company reiterated full-year Adjusted EPS guidance of $1.60 and EBITDA guidance of $805 million. Stock price rose 2% to $26.12 following the report.
Wealthfront Advisers LLC raises stake in Las Vegas Sands Corp
Wealthfront Advisers LLC increased its position in Las Vegas Sands Corp by 40.6% in the fourth quarter, purchasing 19,488 shares to hold a total of 67,446 shares valued at $4.39 million. Other institutional investors, including Allianz Asset Management, SG Americas Securities, and Nordea Investment Management, also significantly increased their holdings. Analysts maintain a consensus 'Moderate Buy' rating with an average target price of $68.28. The company reported quarterly earnings of $0.91 per share, beating estimates, and announced a quarterly dividend of $0.30 per share payable on May 13th.
Speedy Hire PLC shares slide after supply agreement delays
Speedy Hire PLC shares declined following updates indicating slower-than-expected scaling of a supply agreement with a digital marketplace operator. Operational coordination challenges regarding logistics and fulfilment capacity contributed to the delayed ramp-up. Additionally, softer demand patterns across construction segments and broader sector conditions influenced the negative market sentiment and share valuation adjustment.
GenIP PLC shares slide after discounted equity issuance
GenIP PLC shares fell following a discounted equity issuance that expanded the company's share capital. The company directed the raised funds toward staffing expansion, research and development, and operational liquidity. This capital allocation strategy, typical for AIM-listed growth companies, triggered a market recalibration and downward movement in valuation levels as new shares entered circulation at reduced terms.
Lloyds Banking Group reports quarterly financial results
Lloyds Banking Group reported quarterly financial results highlighting core banking operations, net interest income, and lending activity. The bank's revenue composition relies on retail and commercial banking segments, supported by fee-based services. Operations include mortgage lending, consumer loans, corporate financing, and cash management. The update reflects alignment with FTSE indices and ongoing efforts in cost management, digital transformation, and regulatory compliance within the UK financial sector.
PureTech Health retains stake in Seaport Therapeutics following US listing
Seaport Therapeutics, a founded entity of PureTech Health, completed an expanded share offering on the Nasdaq Global Select Market. The transaction was priced at the upper end of its valuation range, generating substantial gross proceeds. PureTech Health (LSE:PRTC) retains a significant equity stake in the newly public neuropsychiatry company. This development reflects the biotechnology sector's trend of incubating standalone entities that progress to independent public financing while maintaining parent company ownership interests.
Number of Yorkshire firms facing critical financial distress lifts by over a third
According to Red Flag Alert data, the number of companies in critical financial distress in Yorkshire rose by 35.6% to 4,352 as of 31 March 2026, compared to the same period in 2025. This increase mirrors national trends, though a seasonal dip occurred in the previous quarter. Julian Pitts of BTG noted that firms are battling higher costs, increased tax pressures, and dwindling consumer demand. While critical distress rose, early-stage distress figures also increased by 10.4% annually but fell 11.9% quarter-on-quarter. Almost every sector saw an annual rise in significant distress except printing and packaging.
iForex CEO says increased marketing spend failed to convert due to IPO delay
iForex CEO Itai Sedah stated that increased marketing expenditure prior to a postponed IPO failed to generate expected new users, resulting in a net loss for the broker in 2025. Despite revenue remaining stable, client acquisition costs rose to $695. The company is now adopting a measured approach to marketing, expanding into the UAE with a Category 5 licence, and integrating AI tools while maintaining current staff levels.
FTSE 100 falls 0.4% in first trading session of May
The FTSE 100 index fell 0.4% to 10,340 during the first trading session of May, driven by declines in banking stocks following NatWest's earnings release and rising tensions in the Middle East. NatWest reported Q1 pretax operating profit of £2.03 billion. Conversely, Pearson rose over 1% on sales growth and Diageo gained 1.6% after US President Donald Trump announced plans to lift tariffs on Scotch whisky. UK house price growth also eased to 0.4% in April.
Meta raises $25 billion bonds as AI debt demand weakens
Meta Platforms successfully launched a $25 billion investment-grade bond offering, attracting $96 billion in orders, though demand fell from $125 billion in October. The bonds priced at wider yield spreads, reflecting shifting investor sentiment and growing caution regarding AI expansion costs. While the company reported strong earnings and raised its 2026 capital expenditure forecast to $125-145 billion, total debt has risen from $27 billion in 2022 to nearly $87 billion. The sale indicates continued investor confidence but highlights increasing costs and selectivity in funding AI infrastructure.
Willis cuts full-year organic revenue growth outlook for corporate risk and broking business
Willis has reduced its full-year organic revenue growth forecast for its corporate risk and broking division to mid-single digits. The adjustment follows a slower start to the year, attributed to Middle East disruption which delayed client activity and new business generation. This outcome reflects a more competitive corporate market than previously anticipated.
ASX shares slide despite market strength
Several ASX-listed companies, including A2 Milk Company Ltd, Cochlear Ltd, CSL Ltd, and Temple & Webster Group Ltd, experienced share price declines in April. Movements were driven by revised financial guidance, softer demand trends, supply chain disruptions, and leadership transitions. While the broader ASX 200 delivered positive performance, these company-specific developments created divergence from the upward market trend, influencing investor sentiment across the healthcare and retail sectors.
Trump administration cannabis reclassification sparks industry confusion and legal challenges
The Trump administration's move to reclassify cannabis to Schedule III has generated contradictory federal guidance, creating uncertainty for US operators regarding banking, taxation, and interstate movement. While pharmaceutical developers are reviving IPO plans due to reduced capital barriers, state-licensed operators face a legal bind from a new DEA registration form that risks exposing them to federal drug trafficking charges. Simultaneously, the German medical cannabis market continues to consolidate, with distributor Fette Pharma exiting restructuring. Cannabis ETFs are regaining investor focus despite ongoing regulatory volatility.
CRH reports first quarter 2026 results with revenue growth and strategic divestitures
CRH reported first quarter 2026 results showing total revenues of US$7.4 billion, a 9% increase year-on-year. The company declared a quarterly dividend of US$0.39 per share and initiated a US$0.3 billion share buyback. Strategic moves included agreeing to divest three non-core businesses for US$1.9 billion and investing US$0.9 billion in nine acquisitions, including Axius Water. While Adjusted EBITDA rose 18% to US$0.6 billion, the company recorded a net loss of US$0.2 billion due to higher depreciation, impairment charges, and interest expenses. CEO Jim Mintern reaffirmed full-year 2026 guidance.
Lightwave Logic integrates polymer modulator platform into GlobalFoundries design kit
Lightwave Logic has integrated its high-speed electro-optic polymer modulator platform into the GlobalFoundries design kit and engaged Michael Best & Friedrich LLP for intellectual property advisory. The company, which reports minimal revenue, has seen its share price surge significantly over the past 30 and 90 days. Analysts suggest a fair value of $14.50 per share, indicating potential undervaluation, though this relies on unproven commercial uptake and future tape-outs at foundry partners like Tower Semiconductor and GlobalFoundries.